These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30700531)

  • 21. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
    Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epilepsy in the mTORopathies: opportunities for precision medicine.
    Moloney PB; Cavalleri GL; Delanty N
    Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
    Leitner DF; Kanshin E; Askenazi M; Siu Y; Friedman D; Devore S; Jones D; Ueberheide B; Wisniewski T; Devinsky O
    PLoS One; 2022; 17(5):e0268597. PubMed ID: 35587487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
    Jeong A; Wong M
    J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D
    Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions.
    Gruber VE; Luinenburg MJ; Colleselli K; Endmayr V; Anink JJ; Zimmer TS; Jansen F; Gosselaar P; Coras R; Scholl T; Blumcke I; Pimentel J; Hainfellner JA; Höftberger R; Rössler K; Feucht M; van Scheppingen J; Aronica E; Mühlebner A
    Epilepsia; 2022 Feb; 63(2):364-374. PubMed ID: 34904712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
    Curatolo P
    Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
    Citraro R; Leo A; Constanti A; Russo E; De Sarro G
    Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mTOR dysregulation and tuberous sclerosis-related epilepsy.
    Curatolo P; Moavero R; van Scheppingen J; Aronica E
    Expert Rev Neurother; 2018 Mar; 18(3):185-201. PubMed ID: 29338461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTOR-therapy and targeted treatment opportunities in mTOR-related epilepsies associated with cortical malformations.
    Auvin S; Baulac S
    Rev Neurol (Paris); 2023 Apr; 179(4):337-344. PubMed ID: 36906459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations.
    Iffland PH; Carson V; Bordey A; Crino PB
    Epilepsia; 2019 Nov; 60(11):2163-2173. PubMed ID: 31625153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions.
    Man A; Di Scipio M; Grewal S; Suk Y; Trinari E; Ejaz R; Whitney R
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR signaling in epilepsy: insights from malformations of cortical development.
    Crino PB
    Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S
    Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
    Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extension of microglial activation is associated with epilepsy and cognitive dysfunction in Tuberous sclerosis complex: A TSPO-PET study.
    Kagitani-Shimono K; Kato H; Soeda F; Iwatani Y; Mukai M; Ogawa K; Tominaga K; Nabatame S; Taniike M
    Neuroimage Clin; 2023; 37():103288. PubMed ID: 36521371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with
    Wang Z; Huang K; Yang X; Shen K; Yang L; Ruan R; Shi X; Wang M; Zhu G; Yang M; Zhang C; Lv S; Yang H; Fan X; Liu S
    Brain Pathol; 2021 Mar; 31(2):346-364. PubMed ID: 33314369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-seizure gene therapy for focal cortical dysplasia.
    Almacellas Barbanoj A; Graham RT; Maffei B; Carpenter JC; Leite M; Hoke J; Hardjo F; Scott-Solache J; Chimonides C; Schorge S; Kullmann DM; Magloire V; Lignani G
    Brain; 2024 Feb; 147(2):542-553. PubMed ID: 38100333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.
    Wong M
    Epilepsia; 2009 Oct; 50 Suppl 9(0 9):34-44. PubMed ID: 19761452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.